Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016 - By: Report

Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData has released a pharmaceutical and healthcare report, “Hepatitis C – Drug Pipeline Analysis and Market Forecasts to 2016”. The report is an essential source of information and analysis on the global hepatitis C market. The report identifies the key trends shaping and driving the global hepatitis C market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to cause significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global hepatitis C sector.

Hepatitis C - Drug report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

GlobalData forecasts the global hepatitis C market to grow at 9.8% annually for the next seven years to reach $8.5 billion by 2016. This growth is primarily attributed to high unmet need in the market which is expected to be served by strong pipeline candidates. The growth will be further supported by the prevalence of the disease. GlobalData has concluded that the global hepatitis C market is underserved by the current product options and so there is significant scope for new entrants to capture value from underserved segments. Designing products with curative properties, high safety profiles and better patient compliance is one of key challenges for this market and could provide a significant market share for any company.

Scope

The scope of the report includes:

* Annualized global hepatitis C market revenues data from 2000 to 2009, forecast for seven years to 2016.
* Key geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.
* Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include protease inhibitors, polymerase inhibitors, toll receptor agonists, drugs with interferon-like actions, HCV inhibitors and immunomodulators.
* Analysis of the current and future market competition in the global hepatitis C market. The key market players covered are Merck, Human Genome Sciences, Novartis, Vertex, Janssen, Mitsubishi, Tibotec and Roche.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future hepatitis C market.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global hepatitis C market.
* Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global hepatitis C market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What’s the next big thing in the global hepatitis C market landscape? – Identify, understand and capitalize.

About the Author

ReportsandReports comprising of an online library of 10,000 reports,in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. ReportsandReports announce to have Hepatitis C-Drug Pipeline Analysis and Market Forecasts to 2016 Market Research Report in its store. Browse all our Market Research Reports details at ReportsandReports.com

Article Directory Source: http://www.articlerich.com/profile/Report/88763

Additional Articles From - Home | Disease & illness | Hepatitis